Japan is expected to use three types of drugs to treat the new type of coronavirus infection (Corona 19): anti-influenza drugs, anti-ebola hemorrhagic fever, and anti-aid drugs.

According to the Nihon Keizai Shimbun (Nikkei), Japanese authorities began a research team centered on the National Medical Research Center and began administering Abigan, an anti-influenza drug that was approved in Japan, to the patient yesterday.

Abigan (general name Favipiravir) is an anti-influenza drug developed by Fujifilm Toyama Chemical, a subsidiary of Fujifilm, Japan, which inhibits the replication of ribonucleic acid (RNA) viruses such as the new influenza.

The drug was approved in 2014 on condition that a new influenza virus, such as Tamiflu, which is not covered by existing anti-influenza drugs, can only be used if judged by the Japanese government, and about 2 million people are stored in Japan.

There is a risk of side effects in the unborn child, which cannot be used by pregnant women, and those who have gout or hyperuricemia have to be carefully judged, Japanese media say.

The Ministry of Health, Labor and Welfare has also announced plans to begin the study of the anti-Ebola hemorrhagic fever drug 'lemdecir'.

Remdesirvir is an unapproved drug, and Nikkei says it will begin clinical trials to be approved as early as February at the end of March.

This drug is known to interfere with the production of RNA, which is necessary for viral propagation.

The Japanese government is also considering administering Kaletra, an anti-HIV drug, to patients with Corona 19.

Kaletra has been reported to have been given to SARS patients with SARS similar to Corona 19, while the virus interferes with the action of an enzyme called protease, which is necessary to expand the infection in the body.

Zhang Dingwei, director of Jin Intan Hospital, Wuhan's respiratory hospital, said in an interview with the Asahi Shimbun reported today that the anti-HIV drug is effective. Revealed.

"My wife has a new pneumonia, but when I took anti-HIV drugs, it soon became negative."

But he added that anti-HIV drugs have no effect on critically ill patients, and they have no choice but to treat the symptom.

(Photo: provided by Japan National Institute of Infectious Diseases, Yonhap News)